Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol (ENESYS)
This study has been completed.
Study NCT00942487   Information provided by Berlin-Chemie Menarini

First Received on July 19, 2009.   Last Updated on July 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Arterial Hypertension
Additional conditions recognized in this trial
Hypertension
Ventricular Dysfunction
Ventricular Dysfunction, Left
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Interventions listed in this trial
Nebilet
Corvitol
Additional drug interventions recognized in this trial
Metoprolol
Metoprolol succinate
Nebivolol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Autonomic Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympatholytics
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Berlin-Chemie Menarini


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services